Dow Up 0.64% Nasdaq Up 0.68%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.76 Down 0.15(2.54%) 4:00PM EDT
|After Hours : 5.77 Up 0.01 (0.17%) 5:51PM EDT
Prev Close:5.91
Open:5.91
Bid:5.68 x 300
Ask:5.78 x 1100
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.68 - 5.98
52wk Range:2.15 - 21.55
Volume:4,297,212
Avg Vol (3m):7,270,110
Market Cap:1.08B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 2.54%1.08B
NVSUp 0.08%230.00B
PFEUp 0.76%193.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback